Diosmin 450 mg + Hesperidine 50 mg
Natural health product licensed in Canada
- Other names
- Cell DioHesp 500 mg, Cell DiosHesp 500 mg, Cell Diosmin-Hesperidin 500 mg, Diosmin and Hesperidin Tablets 500 mg
- Licence holder
- CellChem Pharmaceuticals Inc.
- NPN or DIN-HM
- 80127770
- Status
- Active licence
- Licence date
- 2 November 2023
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Oxyde de fer (Fe2O3), Lauryl sulfate de sodium, Poly(éthylène glycol), Stéarate de magnésium, Gélatine, Gel de silice colloïdal, Oxyde de fer jaune, Phosphate de calcium, dibasique, Dioxyde de titane, Talc, Benzoate de sodium, Polacriline potassium, Dioxyde de silicium colloïdal
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps relieve symptoms of non-complicated venous insufficiency (CVI) such as sensation of swelling, varicose veins, feeling of heaviness, pain, tiredness and itching.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80127770
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.